Statement Of Cash Flows [Abstract]
| Concept |
2022-09-18 to 2023-09-16 |
2021-09-19 to 2022-09-17 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for finance income |
48,000,000
GBP
|
19,000,000
GBP
|
| Adjustments for decrease (increase) in trade and other receivables |
107,000,000
GBP
|
288,000,000
GBP
|
| Adjustments for increase (decrease) in trade and other payables |
15,000,000
GBP
|
512,000,000
GBP
|
| Adjustments for decrease (increase) in biological assets |
9,000,000
GBP
|
4,000,000
GBP
|
| Adjustments for amortisation expense |
82,000,000
GBP
|
68,000,000
GBP
|
| Adjustments for depreciation expense |
804,000,000
GBP
|
802,000,000
GBP
|
| Adjustments for undistributed profits of investments accounted for using equity method |
124,000,000
GBP
|
109,000,000
GBP
|
| Cash flows from (used in) investing activities [abstract] | ||
| Dividends received from investments accounted for using equity method, classified as investing activities |
107,000,000
GBP
|
93,000,000
GBP
|
| Cash flows from (used in) financing activities [abstract] | ||
| Dividends paid to equity holders of parent, classified as financing activities |
345,000,000
GBP
|
380,000,000
GBP
|
| Dividends paid to non-controlling interests, classified as financing activities |
7,000,000
GBP
|
8,000,000
GBP
|